IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study.

Journal Article Accepted manuscript IL-6 receptor inhibition and risk of sarcoidosis: a Mendelian randomization study Get access Sizheng Steven Zhao, Sizheng Steven Zhao Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK Correspondence to: Sizheng S Zhao. Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Science, School of Biological Sciences, Faculty of Biological Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Oxford Road, Manchester, M13 9LJ, UK. Email: Sizheng.zhao@manchester.ac.uk Search for other works by this author on: Oxford Academic PubMed Google Scholar Matthew C Baker, Matthew C Baker Division of Immunology and Rheumatology, Department of Medicine, Stanford University, Stanford, CA, USA Search for other works by this author on: Oxford Academic PubMed Google Scholar James B Galloway James B Galloway Centre for Rheumatic Diseases, King's College London, London, UK Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, kead613, https://doi.org/10.1093/rheumatology/kead613 Published: 17 November 2023 Article history Received: 08 September 2023 Revision received: 10 November 2023 Accepted: 14 November 2023 Published: 17 November 2023